Zinc in PDB 8gsq: Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.

Enzymatic activity of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.

All present enzymatic activity of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.:
1.15.1.1;

Protein crystallography data

The structure of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment., PDB code: 8gsq was solved by S.Aouti, B.Padmanabhan, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 95.39 / 2.10
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 163.793, 202.455, 143.996, 90, 90, 90
R / Rfree (%) 17.4 / 20.8

Other elements in 8gsq:

The structure of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. also contains other interesting chemical elements:

Fluorine (F) 1 atom

Zinc Binding Sites:

The binding sites of Zinc atom in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. (pdb code 8gsq). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 9 binding sites of Zinc where determined in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment., PDB code: 8gsq:
Jump to Zinc binding site number: 1; 2; 3; 4; 5; 6; 7; 8; 9;

Zinc binding site 1 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 1 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn201

b:41.8
occ:1.00
 OD1 A:ASP83 1.9 33.1 1.0
ND1 A:HIS80 2.1 37.3 1.0
ND1 A:HIS63 2.1 37.6 1.0
ND1 A:HIS71 2.3 34.9 1.0
CG A:ASP83 2.8 33.9 1.0
CE1 A:HIS80 3.0 35.0 1.0
OD2 A:ASP83 3.0 34.9 1.0
CE1 A:HIS63 3.1 35.9 1.0
CG A:HIS80 3.1 37.8 1.0
CG A:HIS63 3.1 38.6 1.0
CG A:HIS71 3.2 38.9 1.0
CE1 A:HIS71 3.3 41.0 1.0
CB A:HIS63 3.4 32.6 1.0
CB A:HIS80 3.5 34.6 1.0
CB A:HIS71 3.5 36.7 1.0
O A:LYS136 3.8 39.3 1.0
CA A:HIS71 3.9 39.0 1.0
NE2 A:HIS80 4.1 34.7 1.0
CD2 A:HIS80 4.2 36.5 1.0
NE2 A:HIS63 4.2 40.9 1.0
CB A:ASP83 4.2 29.6 1.0
CD2 A:HIS63 4.2 36.4 1.0
NE2 A:HIS71 4.4 37.3 1.0
CD2 A:HIS71 4.4 35.6 1.0
CA A:ASP83 4.6 31.7 1.0
N A:HIS80 4.7 39.8 1.0
CA A:HIS80 4.7 36.2 1.0
O A:HOH333 4.7 31.9 1.0
N A:GLY72 4.7 36.0 1.0
C A:LYS136 4.8 39.4 1.0
N A:HIS71 4.9 38.9 1.0
N A:ASP83 4.9 31.8 1.0
C A:HIS71 4.9 39.2 1.0
CA A:HIS63 4.9 34.1 1.0

Zinc binding site 2 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 2 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn201

b:34.0
occ:1.00
 OD1 B:ASP83 1.9 24.4 1.0
ND1 B:HIS63 2.1 25.0 1.0
ND1 B:HIS80 2.1 27.6 1.0
ND1 B:HIS71 2.2 28.1 1.0
CG B:ASP83 2.8 29.6 1.0
CE1 B:HIS80 2.9 32.2 1.0
OD2 B:ASP83 3.0 24.8 1.0
CE1 B:HIS63 3.1 28.4 1.0
CG B:HIS63 3.1 27.5 1.0
CE1 B:HIS71 3.1 30.2 1.0
CG B:HIS80 3.1 30.0 1.0
CG B:HIS71 3.2 29.9 1.0
CB B:HIS63 3.4 28.2 1.0
CB B:HIS71 3.6 25.0 1.0
CB B:HIS80 3.6 24.2 1.0
O B:LYS136 3.8 30.5 1.0
CA B:HIS71 3.9 31.1 1.0
NE2 B:HIS80 4.1 31.3 1.0
NE2 B:HIS63 4.2 33.2 1.0
CD2 B:HIS80 4.2 30.4 1.0
CB B:ASP83 4.2 25.8 1.0
CD2 B:HIS63 4.2 30.8 1.0
NE2 B:HIS71 4.2 30.3 1.0
CD2 B:HIS71 4.3 27.3 1.0
CA B:ASP83 4.6 26.9 1.0
N B:HIS80 4.7 31.4 1.0
O B:HOH343 4.7 31.3 1.0
N B:GLY72 4.8 31.9 1.0
CA B:HIS80 4.8 28.4 1.0
C B:LYS136 4.8 31.1 1.0
N B:ASP83 4.9 26.3 1.0
C B:HIS71 4.9 31.4 1.0
CA B:HIS63 4.9 28.4 1.0
N B:HIS71 5.0 29.7 1.0
CD2 B:HIS46 5.0 29.1 1.0

Zinc binding site 3 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 3 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 3 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
C:Zn201

b:46.7
occ:1.00
 OD1 C:ASP83 1.9 41.6 1.0
ND1 C:HIS80 2.0 42.7 1.0
ND1 C:HIS71 2.2 38.9 1.0
ND1 C:HIS63 2.3 34.7 1.0
CG C:ASP83 2.7 39.9 1.0
CE1 C:HIS80 2.8 41.6 1.0
OD2 C:ASP83 2.9 36.8 1.0
CG C:HIS80 3.0 39.9 1.0
CG C:HIS63 3.2 36.2 1.0
CE1 C:HIS71 3.2 34.8 1.0
CG C:HIS71 3.2 42.1 1.0
CE1 C:HIS63 3.3 36.7 1.0
CB C:HIS63 3.4 32.6 1.0
CB C:HIS80 3.5 34.2 1.0
CB C:HIS71 3.5 40.4 1.0
CA C:HIS71 3.9 38.1 1.0
NE2 C:HIS80 3.9 42.3 1.0
O C:LYS136 3.9 40.3 1.0
CD2 C:HIS80 4.0 39.8 1.0
CB C:ASP83 4.2 35.1 1.0
NE2 C:HIS71 4.3 39.4 1.0
CD2 C:HIS71 4.3 37.8 1.0
CD2 C:HIS63 4.3 39.7 1.0
NE2 C:HIS63 4.4 40.5 1.0
N C:HIS80 4.6 36.0 1.0
CA C:ASP83 4.7 33.2 1.0
CA C:HIS80 4.7 31.6 1.0
N C:GLY72 4.8 39.5 1.0
O C:HOH370 4.9 40.6 1.0
CA C:HIS63 4.9 28.5 1.0
C C:HIS71 4.9 43.0 1.0
C C:LYS136 4.9 43.1 1.0
N C:HIS71 4.9 41.8 1.0
N C:ASP83 5.0 31.1 1.0

Zinc binding site 4 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 4 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 4 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Zn201

b:30.4
occ:1.00
 OD1 D:ASP83 1.9 26.7 1.0
ND1 D:HIS80 2.0 28.6 1.0
ND1 D:HIS63 2.1 28.6 1.0
ND1 D:HIS71 2.2 28.1 1.0
CG D:ASP83 2.7 26.9 1.0
CE1 D:HIS80 2.9 26.9 1.0
OD2 D:ASP83 2.9 22.8 1.0
CE1 D:HIS63 3.0 27.5 1.0
CE1 D:HIS71 3.1 26.8 1.0
CG D:HIS80 3.1 23.1 1.0
CG D:HIS63 3.1 27.2 1.0
CG D:HIS71 3.2 28.1 1.0
CB D:HIS63 3.5 25.4 1.0
CB D:HIS80 3.5 25.7 1.0
CB D:HIS71 3.6 29.8 1.0
O D:LYS136 3.8 28.6 1.0
CA D:HIS71 4.0 30.1 1.0
NE2 D:HIS80 4.0 27.5 1.0
CD2 D:HIS80 4.1 27.0 1.0
NE2 D:HIS63 4.1 23.9 1.0
CB D:ASP83 4.1 24.9 1.0
CD2 D:HIS63 4.2 29.2 1.0
NE2 D:HIS71 4.2 30.1 1.0
CD2 D:HIS71 4.3 28.7 1.0
CA D:ASP83 4.6 24.2 1.0
N D:HIS80 4.7 27.0 1.0
CA D:HIS80 4.8 24.6 1.0
N D:GLY72 4.8 27.1 1.0
C D:LYS136 4.8 30.2 1.0
N D:ASP83 4.9 22.9 1.0
O D:HOH379 4.9 32.2 1.0
C D:HIS71 4.9 31.2 1.0
N D:HIS71 5.0 31.8 1.0
CA D:HIS63 5.0 23.9 1.0
CD2 D:HIS46 5.0 26.9 1.0

Zinc binding site 5 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 5 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 5 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
E:Zn201

b:56.5
occ:1.00
 OD1 E:ASP83 2.0 46.1 1.0
ND1 E:HIS80 2.1 50.7 1.0
ND1 E:HIS63 2.2 46.4 1.0
ND1 E:HIS71 2.4 56.5 1.0
CG E:ASP83 2.8 50.1 1.0
OD2 E:ASP83 2.9 50.2 1.0
CE1 E:HIS80 3.0 48.8 1.0
CG E:HIS80 3.1 51.8 1.0
CG E:HIS63 3.1 39.7 1.0
CE1 E:HIS63 3.2 46.5 1.0
CB E:HIS63 3.3 36.7 1.0
CG E:HIS71 3.4 57.4 1.0
CE1 E:HIS71 3.4 56.1 1.0
CB E:HIS80 3.4 46.8 1.0
CB E:HIS71 3.6 53.6 1.0
CA E:HIS71 4.0 57.2 1.0
O E:LYS136 4.0 55.7 1.0
NE2 E:HIS80 4.1 52.0 1.0
CD2 E:HIS80 4.2 54.0 1.0
CB E:ASP83 4.2 46.5 1.0
CD2 E:HIS63 4.3 43.7 1.0
NE2 E:HIS63 4.3 48.4 1.0
NE2 E:HIS71 4.5 58.2 1.0
CD2 E:HIS71 4.5 56.0 1.0
N E:HIS80 4.6 46.6 1.0
CA E:HIS80 4.6 48.6 1.0
CA E:ASP83 4.7 41.8 1.0
CA E:HIS63 4.9 37.6 1.0
N E:GLY72 4.9 58.5 1.0
O E:HOH349 4.9 45.4 1.0
CD2 E:HIS46 5.0 46.1 1.0
C E:LYS136 5.0 62.2 1.0
N E:HIS71 5.0 55.1 1.0
N E:ASP83 5.0 40.3 1.0

Zinc binding site 6 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 6 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 6 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
F:Zn201

b:34.9
occ:1.00
 OD1 F:ASP83 2.0 26.4 1.0
ND1 F:HIS63 2.0 28.0 1.0
ND1 F:HIS80 2.1 24.2 1.0
ND1 F:HIS71 2.1 25.9 1.0
CG F:ASP83 2.8 28.2 1.0
CE1 F:HIS80 2.9 28.4 1.0
OD2 F:ASP83 2.9 26.9 1.0
CE1 F:HIS63 3.0 28.8 1.0
CE1 F:HIS71 3.1 28.9 1.0
CG F:HIS63 3.1 29.3 1.0
CG F:HIS80 3.1 27.2 1.0
CG F:HIS71 3.2 28.7 1.0
CB F:HIS63 3.4 30.8 1.0
CB F:HIS71 3.5 28.9 1.0
CB F:HIS80 3.6 24.0 1.0
O F:LYS136 3.8 30.7 1.0
CA F:HIS71 3.9 31.4 1.0
NE2 F:HIS80 4.0 28.4 1.0
NE2 F:HIS63 4.1 29.3 1.0
CD2 F:HIS80 4.1 29.9 1.0
CD2 F:HIS63 4.2 29.9 1.0
CB F:ASP83 4.2 26.2 1.0
NE2 F:HIS71 4.2 28.6 1.0
CD2 F:HIS71 4.3 23.2 1.0
CA F:ASP83 4.6 25.4 1.0
N F:GLY72 4.7 29.5 1.0
N F:HIS80 4.7 24.8 1.0
CA F:HIS80 4.8 28.5 1.0
C F:LYS136 4.8 29.6 1.0
C F:HIS71 4.9 30.5 1.0
O F:HOH374 4.9 30.8 1.0
N F:ASP83 4.9 24.7 1.0
N F:HIS71 4.9 28.8 1.0
CA F:HIS63 5.0 28.1 1.0

Zinc binding site 7 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 7 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 7 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Zn201

b:45.0
occ:1.00
 OD1 H:ASP83 1.9 39.8 1.0
ND1 H:HIS71 2.1 37.2 1.0
ND1 H:HIS80 2.2 41.6 1.0
ND1 H:HIS63 2.2 37.0 1.0
CG H:ASP83 2.7 44.1 1.0
OD2 H:ASP83 3.0 41.5 1.0
CE1 H:HIS80 3.0 43.3 1.0
CE1 H:HIS71 3.1 38.7 1.0
CG H:HIS71 3.1 38.5 1.0
CG H:HIS63 3.2 40.0 1.0
CG H:HIS80 3.2 44.1 1.0
CE1 H:HIS63 3.2 38.4 1.0
CB H:HIS63 3.4 36.7 1.0
CB H:HIS71 3.4 40.5 1.0
CB H:HIS80 3.6 39.7 1.0
O H:LYS136 3.8 38.8 1.0
CA H:HIS71 3.9 39.5 1.0
NE2 H:HIS80 4.1 50.2 1.0
CB H:ASP83 4.1 42.4 1.0
NE2 H:HIS71 4.2 40.3 1.0
CD2 H:HIS80 4.2 44.9 1.0
CD2 H:HIS71 4.2 38.8 1.0
NE2 H:HIS63 4.3 38.8 1.0
CD2 H:HIS63 4.3 37.6 1.0
CA H:ASP83 4.6 37.0 1.0
N H:HIS80 4.7 40.6 1.0
N H:GLY72 4.7 39.1 1.0
CA H:HIS80 4.7 39.4 1.0
C H:HIS71 4.8 43.2 1.0
N H:ASP83 4.8 37.9 1.0
C H:LYS136 4.8 41.9 1.0
CA H:HIS63 5.0 38.1 1.0
N H:HIS71 5.0 42.4 1.0

Zinc binding site 8 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 8 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 8 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
I:Zn201

b:60.0
occ:1.00
 OD1 I:ASP83 2.0 54.5 1.0
ND1 I:HIS63 2.1 49.6 1.0
ND1 I:HIS80 2.2 51.8 1.0
ND1 I:HIS71 2.3 61.9 1.0
CG I:ASP83 2.7 53.5 1.0
OD2 I:ASP83 2.8 55.6 1.0
CE1 I:HIS80 3.0 52.6 1.0
CG I:HIS63 3.1 50.2 1.0
CE1 I:HIS63 3.1 52.5 1.0
CE1 I:HIS71 3.1 56.8 1.0
CG I:HIS80 3.2 50.5 1.0
CG I:HIS71 3.3 59.9 1.0
CB I:HIS63 3.3 42.3 1.0
CB I:HIS71 3.6 58.1 1.0
CB I:HIS80 3.7 48.0 1.0
O I:LYS136 3.9 59.7 1.0
NE2 I:HIS80 4.1 54.9 1.0
CA I:HIS71 4.1 57.6 1.0
CB I:ASP83 4.1 49.3 1.0
CD2 I:HIS63 4.2 48.8 1.0
NE2 I:HIS63 4.2 45.4 1.0
CD2 I:HIS80 4.2 53.5 1.0
NE2 I:HIS71 4.3 59.5 1.0
CD2 I:HIS71 4.4 57.0 1.0
CA I:ASP83 4.6 49.4 1.0
N I:HIS80 4.8 53.7 1.0
CD2 I:HIS46 4.8 44.8 1.0
CA I:HIS80 4.9 48.6 1.0
CA I:HIS63 4.9 47.2 1.0
N I:GLY72 4.9 59.6 1.0
N I:ASP83 5.0 48.1 1.0
C I:LYS136 5.0 60.3 1.0

Zinc binding site 9 out of 9 in 8gsq

Go back to Zinc Binding Sites List in 8gsq
Zinc binding site 9 out of 9 in the Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment.


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 9 of Structure Based Studies Reveal An Atypical Antipsychotic Drug Candidate - Paliperidone As A Potent HSOD1 Modulator with Implications in Als Treatment. within 5.0Å range:
probe atom residue distance (Å) B Occ
J:Zn201

b:46.0
occ:1.00
 OD1 J:ASP83 1.8 36.7 1.0
ND1 J:HIS71 2.1 39.7 1.0
ND1 J:HIS63 2.2 35.0 1.0
ND1 J:HIS80 2.2 33.4 1.0
CG J:ASP83 2.7 37.3 1.0
OD2 J:ASP83 2.9 35.9 1.0
CE1 J:HIS71 3.0 35.4 1.0
CE1 J:HIS80 3.1 31.5 1.0
CG J:HIS63 3.1 33.7 1.0
CE1 J:HIS63 3.1 41.2 1.0
CG J:HIS80 3.1 36.9 1.0
CG J:HIS71 3.2 37.8 1.0
CB J:HIS63 3.4 37.8 1.0
CB J:HIS80 3.5 35.4 1.0
CB J:HIS71 3.6 37.4 1.0
O J:LYS136 3.8 39.0 1.0
CA J:HIS71 3.9 38.8 1.0
CB J:ASP83 4.1 35.3 1.0
NE2 J:HIS71 4.1 40.5 1.0
NE2 J:HIS80 4.2 38.5 1.0
NE2 J:HIS63 4.2 40.3 1.0
CD2 J:HIS80 4.2 37.1 1.0
CD2 J:HIS63 4.2 39.7 1.0
CD2 J:HIS71 4.2 36.0 1.0
CA J:ASP83 4.5 38.2 1.0
CA J:HIS80 4.7 39.7 1.0
N J:HIS80 4.7 41.1 1.0
N J:ASP83 4.8 35.3 1.0
N J:GLY72 4.8 38.4 1.0
O J:HOH343 4.8 39.7 1.0
C J:LYS136 4.9 38.6 1.0
C J:HIS71 4.9 39.5 1.0
CA J:HIS63 4.9 36.5 1.0
N J:HIS71 4.9 40.5 1.0

Reference:

S.Aouti, S.Padavattan, B.Padmanabhan. Structure-Based Discovery of An Antipsychotic Drug, Paliperidone, As A Modulator of Human Superoxide Dismutase 1: A Potential Therapeutic Target in Amyotrophic Lateral Sclerosis. Acta Crystallogr D Struct V. 79 531 2023BIOL.
ISSN: ISSN 2059-7983
PubMed: 37204819
DOI: 10.1107/S2059798323003649
Page generated: Wed Oct 30 21:04:39 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy